Physician profile
Nicholas J Ahn
NPI 1912341447
$1,706.41
in general payments reported to CMS, 2019-2025
11 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.59 · 2021: $173 · 2022: $213 · 2023: $667 · 2024: $427 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,298.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $524.57 | 2021-2023 | Interstim, Signia |
| Thd America, INC. | $387.67 | 2022-2023 | |
| Virtual Incision Corporation | $184.15 | 2024-2025 | Mira |
| Stryker Corporation | $147.12 | 2025 | 1788 |
| Galvanize Therapeutics, INC | $144.11 | 2024 | Aliya System |
| Olympus Corporation of The Americas | $101.00 | 2023 | Evis Exera Lll Colonovideoscope |
| Guard Medical INC. | $82.07 | 2024 | Npseal Large |
| Abbott Laboratories | $78.37 | 2023-2024 | Freestyle Libre 3 |
| Abbvie INC. | $22.05 | 2024 | |
| Intuitive Surgical, INC. | $21.59 | 2020 | |
| Novo Nordisk INC | $13.71 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Ahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.